In the present study, we evaluated plasma ANGPTL8 concentrations 6 months after sleeve gastrectomy and RYGB in patients with obesity and biopsy-proven NAFLD. The gene discussed is ANGPTL8; the disease is metabolic dysfunction-associated steatotic liver disease.